162 related articles for article (PubMed ID: 21251322)
21. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F
Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia.
Rabin KR; Man TK; Yu A; Folsom MR; Zhao YJ; Rao PH; Plon SE; Naeem RC
Pediatr Blood Cancer; 2008 Aug; 51(2):171-7. PubMed ID: 18253961
[TBL] [Abstract][Full Text] [Related]
23. High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia.
Othman MA; Melo JB; Carreira IM; Rincic M; Glaser A; Grygalewicz B; Gruhn B; Wilhelm K; Rittscher K; Meyer B; Silva ML; de Jesus Marques Salles T; Liehr T
Mol Cytogenet; 2015; 8():45. PubMed ID: 26136832
[TBL] [Abstract][Full Text] [Related]
24. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
Ahmad A; Iqbal MA
Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
[TBL] [Abstract][Full Text] [Related]
25. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel.
Alvarez S; Cigudosa JC
Hematol Oncol; 2005 Mar; 23(1):18-25. PubMed ID: 16142824
[TBL] [Abstract][Full Text] [Related]
26. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.
Asai A; Karnan S; Ota A; Takahashi M; Damdindorj L; Konishi Y; Hossain E; Konishi H; Nagata A; Yokoo K; Hosokawa Y
Gene; 2015 Mar; 558(2):220-6. PubMed ID: 25562418
[TBL] [Abstract][Full Text] [Related]
27. Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
Kamath A; Tara H; Xiang B; Bajaj R; He W; Li P
Cancer Genet Cytogenet; 2008 Jun; 183(2):117-20. PubMed ID: 18503831
[TBL] [Abstract][Full Text] [Related]
28. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
29. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
30. The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes.
Kim MH; Stewart J; Devlin C; Kim YT; Boyd E; Connor M
Cancer Genet Cytogenet; 2001 Apr; 126(1):26-33. PubMed ID: 11343775
[TBL] [Abstract][Full Text] [Related]
31. Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.
Konialis C; Savola S; Karapanou S; Markaki A; Karabela M; Polychronopoulou S; Ampatzidou M; Voulgarelis M; Viniou NA; Variami E; Koumarianou A; Zoi K; Hagnefelt B; Schouten JP; Pangalos C
Hematology; 2014 Jun; 19(4):217-24. PubMed ID: 23928116
[TBL] [Abstract][Full Text] [Related]
32. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
33. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
34. Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects.
Hussein IR; Bader RS; Chaudhary AG; Bassiouni R; Alquaiti M; Ashgan F; Schulten HJ; Al Qahtani MH
Pediatr Cardiol; 2018 Jun; 39(5):924-940. PubMed ID: 29541814
[TBL] [Abstract][Full Text] [Related]
35. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
[TBL] [Abstract][Full Text] [Related]
36. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
37. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
38. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma.
Stallings RL; Nair P; Maris JM; Catchpoole D; McDermott M; O'Meara A; Breatnach F
Cancer Res; 2006 Apr; 66(7):3673-80. PubMed ID: 16585193
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
Kawankar N; Jijina F; Ghosh K; Vundinti BR
Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
[TBL] [Abstract][Full Text] [Related]
40. Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Ciabatti E; Valetto A; Bertini V; Ferreri MI; Guazzelli A; Grassi S; Guerrini F; Petrini I; Metelli MR; Caligo MA; Rossi S; Galimberti S
Oncotarget; 2017 Oct; 8(45):79188-79200. PubMed ID: 29108298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]